Showing results (201-210 of 2,170) with videos related to
Sort By:
Pageof 217
American Journal of Epidemiology|March 1, 1988
Human T-cell lymphotropic virus type I (HTLV-I) seroepidemiology and risk factors in metropolitan PanamáW C Reeves, C Saxinger, M M Brenes, et al.Cellular Immunology|July 15, 1983
Stimulation of lymphokine production by teleocidin, aplysiatoxin, and debromoaplysiatoxinY K Yip, H C Kelker, D S Stone-Wolff, et al.Biochemistry|June 24, 1998
Colocalization of heparin and receptor binding sites on keratinocyte growth factorP J Kim, K Sakaguchi, H Sakamoto, et al.Journal of Acquired Immune Deficiency Syndromes|January 1, 1990
A study of HTLV-I and its associated risk factors in Trinidad and TobagoW A Blattner, C Saxinger, D Riedel, et al.International Journal of Cancer|October 15, 1986
STLV-I antibodies in feral populations of East African vervet monkeys (Cercopithecus aethiops)N C Dracopoli, T R Turner, J G Else, et al.Journal of Virology|July 1, 1992
In vivo genetic variability of the human immunodeficiency virus type 2 V3 regionE Boeri, A Giri, F Lillo, et al.Scandinavian Journal of Immunology|March 1, 1985
Antibodies to human T lymphotropic virus type III demonstrated by a dot immunobinding assayG Biberfeld, U Bredberg-Råden, B Böttiger, et al.The American Journal of Medicine|October 1, 1986
Normal T cell subsets in homosexual men living in a community without endemic AIDST J Rush, R F Betts, C Saxinger, et al.Journal of Clinical Immunology|September 1, 1987
Immune impairments and antibodies to HTLVIII/LAV in asymptomatic male homosexuals in Israel: relevance to the risk of acquired immune deficiency syndrome (AIDS)Z Bentwich, C Saxinger, Z Ben-Ishay, et al.Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|April 1, 1994
Monocyte activation following systemic administration of granulocyte-macrophage colony-stimulating factorA Chachoua, R Oratz, R Hoogmoed, et al.Pageof 217